Peptable

Comparison

CJC-1295 vs Ipamorelin

Function

While CJC-1295 is used in research to chronically elevate endogenous growth hormone and IGF-1 levels, enabling studies of body composition, metabolic, and anti-aging effects of prolonged GH exposure10, Ipamorelin is investigated for producing moderate, physiologic-like GH pulses useful for studying anabolic, body-composition, and recovery effects with a relatively clean endocrine side-effect profile compared with earlier GHRPs16.

Mechanism

While CJC-1295 works as a tetrasubstituted 29-amino-acid analog of GHRH(1–29) that acts as a potent agonist at the GHRH receptor and, in its DAC form, covalently binds serum albumin to extend half-life from minutes to days, resulting in sustained pulsatile GH and IGF-1 increase1082, Ipamorelin is a third-generation pentapeptide growth hormone secretagogue that selectively agonizes the ghrelin (GHSR-1a) receptor to trigger controlled, GH-specific pituitary release with minimal effects on cortisol or prolactin16269596.

Receptor

CJC-1295

Growth hormone–releasing hormone receptor (GHRHR) on anterior pituitary somatotrophs1094103

Ipamorelin

Ghrelin/growth hormone secretagogue receptor type 1a (GHSR-1a)169596104

Organism or Origin

CJC-1295

Synthetic peptide based on human hypothalamic GHRH10120

Ipamorelin

Fully synthetic peptide ghrelin mimetic16

Gene

CJC-1295

GHRH

Ipamorelin

GHSR

Summary

Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Both are often discussed in Metabolic and endocrine contexts, while CJC-1295 is more of a hormone peptide and Ipamorelin is better described as a hormone peptide. Both appear to work through Receptor agonist, but the functional emphasis still separates, with CJC-1295 leaning toward Metabolic regulation and Ipamorelin leaning toward Anabolic growth and Lipolysis and fat loss. CJC-1295 has a more synthetic analog origin, while Ipamorelin is closer to synthetic design background and both are still best understood as being in Preclinical development. CJC-1295 takes the form of a peptide conjugate, whereas Ipamorelin is closer to a linear peptide, while their sequence patterns also diverge, with CJC-1295 showing alpha-helical domain features and Ipamorelin showing protein-mimetic sequence features.

Sources

10CJC-1295: Long-Acting GHRH Analog - Alpha Carbon Labs, https://alphacarbonlabs.com/blog/cjc-1295-long-acting-ghrh-analog
82CJC-1295 no DAC 5mg (Mod GRF 1-29), https://www.peptidesciences.com/mod-grf-1-29-5mg-cjc-1295-no-dac
94Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth-hormone-releasing_hormone_receptor
103Growth-hormone-releasing hormone receptor - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone_releasing_hormone_receptor
120Growth hormone–releasing hormone - Wikipedia, https://en.wikipedia.org/wiki/Growth_hormone%E2%80%93releasing_hormone
16Ipamorelin peptide: A gentle pulse, but is it strong enough?, https://oathpeptides.com/2025/11/05/ipamorelin-peptide-a-gentle-pulse-but-is-it-strong-enough/
96Growth Hormone Secretagogue Receptor - ScienceDirect.com, https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/growth-hormone-secretagogue-receptor